(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Pancreatic Adenocarcinoma
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Small moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 73/ 100
Competitive context
76 Active assets in the Pancreatic Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Jonsson Comprehensive Cancer Center | Phase 4 | BBB |
Irinotecan Jonsson Comprehensive Cancer Center | Phase 3 | BB |
Calcium folinate pentahydrate Jonsson Comprehensive Cancer Center | Phase 4 | BB |
Eloxatin Jonsson Comprehensive Cancer Center | Phase 4 | BB |
Capecitabine Zhejiang University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →